Alumis Quarterly Cash Flow Statement
NASDAQ: ALMSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.16+0.19 (+2.73%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Alumis free cash flow
In the quarter ended Jun 30, 2026, Alumis generated -$81.5 million of operating cash flow and spent $237,000 on capital expenditures. That left free cash flow of -$81.7 million, a free-cash-flow margin of -4918.0% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Alumis cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -142.22M | -93.05M | -92.93M | -110.75M | 59.32M | -98.96M | -94.76M | -93.12M | -56.51M | -49.85M | -39.30M | -43.38M |
| Net Income growth (YoY) | -339.75% | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 874.00K | 871.00K | 867.00K | 916.00K | 870.00K | 843.00K | 820.00K | 814.00K | 760.00K | 758.00K | 726.00K | 318.00K |
| Stock-Based Compensation | 14.27M | 12.34M | 8.11M | 9.79M | 18.64M | 7.00M | 6.36M | 7.31M | 3.13M | 2.66M | 2.62M | 2.27M |
| Change in Working Capital | 1.60M | 3.69M | 7.67M | -11.09M | 989.00K | 1.04M | 1.92M | -3.69M | 1.86M | 5.55M | -3.48M | 1.99M |
| Operating Cash Flow | -81.50M | -87.08M | -71.91M | -110.91M | -106.35M | -80.36M | -74.76M | -83.77M | -52.29M | -44.26M | -33.73M | -33.25M |
| Capital Expenditures | -237.00K | -164.00K | 0 | 0 | -616.00K | -37.00K | -366.00K | -779.00K | -432.00K | -155.00K | -1.21M | -2.17M |
| Investing Cash Flow | 68.69M | -285.69M | 95.01M | 24.04M | 129.40M | 39.43M | 30.95M | -93.19M | -32.74M | -18.81M | -4.14M | 7.58M |
| Share Repurchases | — | — | 0 | 0 | — | — | 0 | — | — | — | 0 | -13.00K |
| Financing Cash Flow | 12.63M | 346.99M | 1.32M | 0 | — | — | 5.00K | 235.15M | 128.06M | 129.15M | 29.72M | 47.00K |
| Net Change in Cash | -179.00K | -25.78M | 24.42M | -86.87M | 23.80M | -40.93M | -43.81M | 58.20M | 43.04M | 66.08M | -8.15M | -25.62M |
| Free Cash Flow | -81.74M | -87.25M | -71.91M | -110.91M | -106.97M | -80.39M | -75.13M | -84.55M | -52.72M | -44.42M | -34.94M | -35.41M |
This table shows 12 quarterly periods of Alumis's cash flow statement, from Q2 2026 back to Q3 2023, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ALMS's reporting calendar. What is a cash flow statement?